New AI capabilities help DBAs move from performance visibility to performance resolution--turning slow queries into actionable index recommendations in minutes HOUSTON, March 19, 2026 /PRNewswire/ -- ...

NEW YORK, Dec 19 (Reuters) - Idera Pharmaceuticals Inc on Wednesday said it had agreed to a partnership under which it will license technology to German drugmaker Merck KGaA for cancer treatments.

On a big day for biotech stocks, few appear to have benefited as much as Idera Pharmaceuticals (IDRA) , which is trading up about 17.25 percent. The stock gapped up just $0.02 a share at the open but ...

Shares in Small-Cap Star Idera Pharmaceuticals (IDRA) are up today following the announcement of an agreement with Abbott Laboratories (ABT) to develop a companion diagnostics test for use in clinical ...

Idera Pharmaceuticals' stock market rollercoaster ride left it partially recovered from its 25% plunge just over a week ago upon FDA approval of a competing product developed by Celgene . Idera's ...

Idera Inc, a Houston-based software company, is reorganizing its business model to focus on application performance monitoring — which includes selling off its ...

Idera, Inc. has announced the general availability of SQL Diagnostic Manager 13.0. This release introduces integration with Microsoft Entra ID authentication, enhancing the credential management ...

* Idera Pharmaceuticals advances investigational treatment – intratumoral IMO-2125 in combination with ipilimumab - for unmet need in anti-PD-1 refractory metastatic melanoma Sign up here. * Idera ...

Idera Pharmaceuticals, Inc. IDRA announced today the presentation of IMO-3100 mechanism of action data in a preclinical model of arthritis. In this study, the improvements in disease-related ...